EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Toxicological Evaluation and Safety Assessment of Perilla frutescens Leaf Extract: Repeated-Dose Oral Toxicity and Genotoxicity Studies

Je-Ho Lee, Ki Hwan Park iD, Mi-Yeong An iD, Jong Soon Kang, Song-Kyu Park iD

Foods · 28.10.2026 · 15 (21) · 3852

DOI: 10.3390/foods15213852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Foods, online erschienen am 28.10.2026. Verfasst von Je-Ho Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Daehan Cellpharm Co., Ltd., 116, Donggureung-ro, Guri-si 11905, Republic of Korea. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Korea Research Institute of Bioscience and Biotechnology, Ministry of Trade, Industry and Energy, Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perilla frutescens var. frutescens leaf extract (PFE) has previously demonstrated clinical efficacy in relieving knee joint discomfort. To establish its safety profile, good laboratory practice (GLP)-compliant nonclinical evaluations were conducted in accordance with the Organization for Economic Cooperation and Development (OECD) test guidelines. In the acute oral toxicity test, the acute oral LD50 cutoff was estimated to be above 2000 mg/kg. In 28-day and 90-day repeated-dose oral toxicity studies of up to 5000 mg/kg/day, no mortalities, toxic signs, or adverse changes in body weight were observed. Minor hematological/biochemical shifts and organ weight increases at 5000 mg/kg/day lacked histopathological correlates and were largely reversible following a 28-day recovery period, establishing the no observed adverse effect level (NOAEL) at 5000 mg/kg/day. Furthermore, PFE showed no mutagenic, clastogenic, or aneugenic potential across the bacterial reverse mutation, in vitro chromosomal aberration, or in vivo bone marrow micronucleus assays. These results demonstrate a broad safety margin, supporting the safe application of PFE as a functional food ingredient and nutraceutical agent.

Schlagwörter

Stichwörter der Autor:innen

Perilla frutescensgenotoxicityoral toxicityrosmarinic acid

Autor:innen und Institutionen

  • Daehan Cellpharm Co., Ltd., 116, Donggureung-ro, Guri-si 11905, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Korea University, 2511, Sejong-ro, Sejong-si 30019, Republic of Korea.
  • Laboratory Animal Resource and Research Center, Korea Research Institute of Bioscience and Biotechnology, 30, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si 28116, Republic of Korea.

ORCID-Profile: Ki Hwan Park, Mi-Yeong An, Song-Kyu Park

Förderung

  • Ministry of Trade, Industry and Energy
  • Korea Research Institute of Bioscience and Biotechnology
  • Ministry of Trade, Industry and Energy, Korea
  • Korea Institute for Advancement of Technology

Zitieren

APA

Lee, J. H., Park, K. H., An, M. Y., Kang, J. S., & Park, S. K. (2026). Comprehensive Toxicological Evaluation and Safety Assessment of Perilla frutescens Leaf Extract: Repeated-Dose Oral Toxicity and Genotoxicity Studies. Foods, 15(21), 3852. https://doi.org/10.3390/foods15213852

Vancouver

Lee JH, Park KH, An MY, Kang JS, Park SK. Comprehensive Toxicological Evaluation and Safety Assessment of Perilla frutescens Leaf Extract: Repeated-Dose Oral Toxicity and Genotoxicity Studies. Foods. 2026;15(21):3852. doi:10.3390/foods15213852

BibTeX
@article{Lee2026,
  author = {Lee, Je-Ho and Park, Ki Hwan and An, Mi-Yeong and Kang, Jong Soon and Park, Song-Kyu},
  title = {Comprehensive Toxicological Evaluation and Safety Assessment of Perilla frutescens Leaf Extract: Repeated-Dose Oral Toxicity and Genotoxicity Studies},
  journal = {Foods},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {3852},
  doi = {10.3390/foods15213852}
}
Kostenlos starten →